Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

Share Price is delayed by 15 minutes
Get Live Data
928.00    -8.00 (-0.85%)
Bid:
924.00
Ask:
936.00
Spread: 12.00 (1.299%)
Market Cap: £254.00m
GHH Live PriceLast checked at - London Stock Exchange

Intraday Gooch & Housego Share Chart

Acquisition

7 Feb 2006 07:02

Gooch & Housego PLC07 February 2006 For Immediate Release 7 February 2006 Gooch & Housego PLC ACQUISITION OF CHROMODYNAMICS, INC. Gooch & Housego, the specialist manufacturer of advanced optoelectroniccomponents, materials, instruments and systems, is pleased to announce that ithas acquired ChromoDynamics, Inc. (CDI). Based in the USA, CDI is a developer ofhyperspectral imaging systems. Designed initially for use in conjunction withhigh-end research microscopes, the products are targeted at biomedical research,drug development and medical diagnostics. Future products will address a broadrange of applications including remote sensing and semiconductor inspectionsystems. CDI was founded in 1997 to transfer technology developed at Carnegie MellonUniversity ("CMU"), Pittsburgh, Pennsylvania, into the commercial realm, andbenefited from grants from the National Institutes of Health (NIH) and otherfunding bodies. CDI licenses key patents from CMU (exclusive to its targetmarkets) and has also developed its own intellectual property. Biomedicalimaging systems based on this technology have the potential to improve detectionof cancer and aid in drug development. Three first generation products have beensold to leading biomedical research and pharmaceutical organisations, and afourth to a manufacturer of semiconductor inspection equipment. CDI is now ready to commercialise the technology and make the transition fromresearch and development to production. Manufacturing resources and expertisewithin Gooch & Housego in acousto-optic tuneable filters (the key activecomponent in the system), spectroscopic instrumentation and electronics willenable CDI to achieve the scale necessary to address the market opportunity.Initial sales are expected in the 2007 financial year. The current sole employeeand co-founder will remain with CDI as Vice President of R&D and will providethe foundation for the new team. The consideration for the acquisition is $1,180,000 payable in cash oncompletion. During the year to 30 June 2005, CDI had an income of $229k and made a loss of$78,000. As at 31 May 2005, CDI had net assets of $26,000. Contacts: Gareth Jones, Chairman and Chief Executive Officer, 01460 52271 Tim Thompson, Buchanan Communication Ltd, 020 7466 5000 Andrew Edwards, Oriel Securities Limited, 020 7710 7600 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
21st Dec 202210:02 amRNSPosting of Annual Report and Notice of AGM
20th Dec 202212:30 pmRNSDirector/PDMR Shareholding
6th Dec 20224:26 pmRNSDirector/PDMR Shareholding
6th Dec 20229:38 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSResults for the year ended 30 September 2022
25th Nov 20223:17 pmRNSHolding(s) in Company
23rd Nov 20224:27 pmRNSHolding(s) in Company
18th Nov 20222:20 pmRNSHolding(s) in Company
2nd Nov 20227:00 amRNSNotification of Full Year Results
27th Oct 202212:56 pmRNSHolding(s) in Company
18th Oct 20222:50 pmRNSHolding(s) in Company
26th Aug 20221:00 pmRNSDirector/PDMR Shareholding
19th Aug 202212:24 pmRNSNotification of Major Holdings
19th Aug 202212:19 pmRNSNotification of Major Holdings
17th Aug 202212:00 pmRNSDirector/PDMR Shareholding
17th Aug 202211:57 amRNSDirector/PDMR Shareholding
17th Aug 202211:54 amRNSDirector/PDMR Shareholding
17th Aug 20227:00 amRNSTrading Update and Directorate Changes
13th Jun 202212:58 pmRNSHolding(s) in Company
7th Jun 20227:00 amRNSInterim Results
23rd May 20224:41 pmRNSSecond Price Monitoring Extn
23rd May 20224:36 pmRNSPrice Monitoring Extension
11th May 20227:00 amRNSNotification of Half Year Results
5th Apr 20227:00 amRNSHalf Year Trading Update
23rd Feb 20221:11 pmRNSResult of AGM
23rd Feb 20227:00 amRNSAGM Trading Update
9th Feb 20224:35 pmRNSPrice Monitoring Extension
13th Jan 20227:00 amRNSGrant of LTIP Awards
12th Jan 202212:18 pmRNSHolding(s) in Company
30th Dec 20214:41 pmRNSSecond Price Monitoring Extn
30th Dec 20214:36 pmRNSPrice Monitoring Extension
17th Dec 20217:00 amRNSPosting of Annual Report and AGM Notice
30th Nov 20217:00 amRNSResults for the year ended 30 September 2021
17th Nov 20217:00 amRNSNotification of Full Year Results
25th Oct 20214:41 pmRNSSecond Price Monitoring Extn
25th Oct 20214:35 pmRNSPrice Monitoring Extension
5th Oct 20217:00 amRNSFull Year Trading Update
18th Aug 20217:00 amRNSDiversity Underpins Competitive Advantage
27th Jul 202112:20 pmRNSUpdate on 2021 AGM Resolutions
9th Jun 20213:58 pmRNSPosting of Interim Report
3rd Jun 20217:00 amRNSHolding(s) in Company
1st Jun 20217:00 amRNSInterim Results
10th May 20217:00 amRNSNotification of Half Year Results
28th Apr 20213:20 pmRNSHolding(s) in Company
7th Apr 20217:00 amRNSHalf Year Trading Update
26th Mar 20217:00 amRNSGrant of SAYE Options
12th Mar 20217:00 amRNSAppointment of Non-Executive Director
11th Mar 20214:59 pmRNSPCA to the Chairman Share Purchase
24th Feb 20211:01 pmRNSResult of AGM
24th Feb 20217:00 amRNSAGM Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.